descriptionPublicationkeyboard_double_arrow_right Article 07 Feb 1980 English Publisher:Massachusetts Medical SocietyJournal:New England Journal of Medicine, volume 302, pages 334-335 (issn: 0028-4793, eissn: 1533-4406,

Authors: J Fitzpatrick; E P Getaz; A Dozier; S Beckley;

doi: 10.1056/nejm198002073020607

pmid: 7188625

Cisplatin-Induced Hemolysis

- Summary
- Subjects
- Metrics

Abstract

CISPLATIN (cis-diamminedichloroplatinum) has been tested extensively against various solid tumors and has become commercially available. Recently, we saw two patients who had positive responses to ...

Keywords

Adult, Male, Anemia, Hemolytic, Carcinoma, Transitional Cell, Time Factors, Teratoma, Middle Aged, Hemolysis, Coombs Test, Testicular Neoplasms, Urinary Bladder Neoplasms, Lymphatic Metastasis, Humans, Cisplatin

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	98
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 1%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%